Sun, W.; Wu, Y.; Ma, F.; Fan, J.; Qiao, Y.
Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis. J. Clin. Med. 2023, 12, 1588.
https://doi.org/10.3390/jcm12041588
AMA Style
Sun W, Wu Y, Ma F, Fan J, Qiao Y.
Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine. 2023; 12(4):1588.
https://doi.org/10.3390/jcm12041588
Chicago/Turabian Style
Sun, Wanyi, Yun Wu, Fei Ma, Jinhu Fan, and Youlin Qiao.
2023. "Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis" Journal of Clinical Medicine 12, no. 4: 1588.
https://doi.org/10.3390/jcm12041588
APA Style
Sun, W., Wu, Y., Ma, F., Fan, J., & Qiao, Y.
(2023). Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine, 12(4), 1588.
https://doi.org/10.3390/jcm12041588